Cargando…
Treatment and vaccines for severe acute respiratory syndrome
The causative agent of severe acute respiratory syndrome (SARS), which affected over 8000 individuals worldwide and was responsible for over 700 deaths in the 2002–2003 outbreak, is a coronavirus that was unknown before the outbreak. Although many different treatments were used during the outbreak,...
Autores principales: | Groneberg, David A, Poutanen, Susan M, Low, Donald E, Lode, Hartmut, Welte, Tobias, Zabel, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106466/ https://www.ncbi.nlm.nih.gov/pubmed/15766649 http://dx.doi.org/10.1016/S1473-3099(05)01307-1 |
Ejemplares similares
-
Molecular mechanisms of severe acute respiratory syndrome (SARS)
por: Groneberg, David A, et al.
Publicado: (2005) -
Pulmonary pathology of severe acute respiratory syndrome in Toronto
por: Hwang, David M, et al.
Publicado: (2005) -
Severe Acute Respiratory Syndrome–associated Coronavirus in Lung Tissue
por: Mazzulli, Tony, et al.
Publicado: (2004) -
Treatment of Severe Acute Respiratory Syndrome
por: Hui, David S.C., et al.
Publicado: (2004) -
Severe acute respiratory syndrome (SARS) vaccines
por: Haagmans, Bart L., et al.
Publicado: (2008)